BioCurex, Inc.(fka BOCX)

[Kag]

"BioCurex was also approached by four dominant companies in the industry at the congresses. In the upcoming weeks, BioCurex will be structuring several programs by which these companies will provide us with encoded samples in order to confidentially validate our claims in unbiased "blind" tests. This procedure is a common and necessary step in the process of licensing any new biotechnology."

Smartinvestor,
Thanks for your post. The "unbiased blind tests" mentioned in the above seems to give an indication of the source and reason for the data that was provided to investors in last Tuesday's press release.

The question that also immediately arises is the part about "in order to confidentially validate our claims". Last Tuesday's press release seems to have thrown some of the "confidentially" out the window. kag